Improvement of the slide hemagglutination test for rapid Chagas' disease screening in epidemiological surveys. 1996

T K Nagasse-Sugahara, and S Hoshino-Shimizu, and R C Pagliarini, and B J Celeste
Divisão de Biologia Médica, Instituto Adolfo Lutz, São Paulo, Brasil.

A slide hemagglutination test, here called SHAT, which is practical and economical for seroepidemiological surveys was standardized. This is an improved modification of the rapid hemagglutination test (RHA) which utilizes a short-lived reagent prepared with fresh blood cells. The reagent and conditions of the test were considerably modified and, most importantly, an alkaline-solubilized Trypanosoma cruzi epimastigote antigen reagent is proposed. The stability of the SHAT reagent was at least one year at 4 degrees C, in an appropriate liquid suspension. The SHAT was applied to 71 serum samples from patients with Chagas' disease and from 235 clinically healthy blood donors. Sensitivity, specificity and positive and negative predictive values for the selected cutoff titer corresponding to 1:4 dilution were 0.972 (0.903-0.992), 0.983 (0.957-0.993), 0.945 (0.867-0.979) and 0.991 (0.969-0.998), respectively. These values were comparable to those found for the RHA, immunofluorescence (IFT), indirect hemagglutination (IHAT) and complement fixation (CFT) tests. These data suggest that the SHAT should be useful for seroepidemiological surveys conducted at public health laboratories in developing countries.

UI MeSH Term Description Entries
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D006386 Hemagglutination Tests Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed) Hemagglutination Test,Test, Hemagglutination,Tests, Hemagglutination
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014355 Chagas Disease Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON. Trypanosomiasis, South American,American Trypanosomiasis,Chagas' Disease,Trypanosoma cruzi Infection,Infection, Trypanosoma cruzi,Infections, Trypanosoma cruzi,South American Trypanosomiasis,Trypanosoma cruzi Infections,Trypanosomiasis, American
D016036 Seroepidemiologic Studies EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases. Seroprevalence,Seroepidemiologic Study,Seroepidemiological Study,Studies, Seroepidemiologic,Study, Seroepidemiologic,Seroepidemiological Studies,Seroprevalences,Studies, Seroepidemiological,Study, Seroepidemiological

Related Publications

T K Nagasse-Sugahara, and S Hoshino-Shimizu, and R C Pagliarini, and B J Celeste
August 1962, Prensa medica argentina,
T K Nagasse-Sugahara, and S Hoshino-Shimizu, and R C Pagliarini, and B J Celeste
December 1969, American journal of clinical pathology,
T K Nagasse-Sugahara, and S Hoshino-Shimizu, and R C Pagliarini, and B J Celeste
January 2013, International journal of immunopathology and pharmacology,
T K Nagasse-Sugahara, and S Hoshino-Shimizu, and R C Pagliarini, and B J Celeste
January 1973, Boletin chileno de parasitologia,
T K Nagasse-Sugahara, and S Hoshino-Shimizu, and R C Pagliarini, and B J Celeste
January 1996, Revista da Sociedade Brasileira de Medicina Tropical,
T K Nagasse-Sugahara, and S Hoshino-Shimizu, and R C Pagliarini, and B J Celeste
March 1956, The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku,
T K Nagasse-Sugahara, and S Hoshino-Shimizu, and R C Pagliarini, and B J Celeste
July 1964, American journal of obstetrics and gynecology,
T K Nagasse-Sugahara, and S Hoshino-Shimizu, and R C Pagliarini, and B J Celeste
March 1970, Vox sanguinis,
T K Nagasse-Sugahara, and S Hoshino-Shimizu, and R C Pagliarini, and B J Celeste
June 1951, American review of tuberculosis,
T K Nagasse-Sugahara, and S Hoshino-Shimizu, and R C Pagliarini, and B J Celeste
February 1963, The Journal of parasitology,
Copied contents to your clipboard!